| Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence JL Raoul, A Forner, L Bolondi, TT Cheung, R Kloeckner, T de Baere Cancer treatment reviews 72, 28-36, 2019 | 471 | 2019 |
| Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma KKC Ng, KSH Chok, ACY Chan, TT Cheung, TCL Wong, JYY Fung, ... Journal of British Surgery 104 (13), 1775-1784, 2017 | 285 | 2017 |
| Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience TT Cheung, RTP Poon, WK Yuen, KSH Chok, CR Jenkins, SC Chan, ... Annals of surgery 257 (3), 506-511, 2013 | 279 | 2013 |
| Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation J Fung, C Cheung, SC Chan, MF Yuen, KSH Chok, W Sharr, WC Dai, ... Gastroenterology 141 (4), 1212-1219, 2011 | 235 | 2011 |
| Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma VWT Lam, KKC Ng, KSH Chok, TT Cheung, J Yuen, H Tung, WK Tso, ... Journal of the American College of Surgeons 207 (1), 20-29, 2008 | 202 | 2008 |
| Pure laparoscopic hepatectomy versus open hepatectomy for hepatocellular carcinoma in 110 patients with liver cirrhosis: a propensity analysis at a single center TT Cheung, WC Dai, SHY Tsang, ACY Chan, KSH Chok, SC Chan, ... Annals of surgery 264 (4), 612-620, 2016 | 191 | 2016 |
| Phase 2 open‐label study of single‐agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B–endemic Asian population: Presence of lung metastasis predicts … T Yau, P Chan, KK Ng, SH Chok, TT Cheung, ST Fan, RT Poon Cancer 115 (2), 428-436, 2009 | 188 | 2009 |
| Octamer 4/microRNA‐1246 signaling axis drives Wnt/β‐catenin activation in liver cancer stem cells S Chai, KY Ng, M Tong, EY Lau, TK Lee, KW Chan, YF Yuan, TT Cheung, ... Hepatology 64 (6), 2062-2076, 2016 | 183 | 2016 |
| SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop CP Cui, CCL Wong, AKL Kai, DWH Ho, EYT Lau, YM Tsui, LK Chan, ... Gut 66 (12), 2149-2159, 2017 | 171 | 2017 |
| Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of … CX Wu, XQ Wang, SH Chok, K Man, SHY Tsang, ACY Chan, KW Ma, ... Theranostics 8 (14), 3737, 2018 | 167 | 2018 |
| Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma DWH Ho, YM Tsui, LK Chan, KMF Sze, X Zhang, JWS Cheu, YT Chiu, ... Nature Communications 12 (1), 3684, 2021 | 161 | 2021 |
| Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? ACY Chan, SC Chan, KSH Chok, TT Cheung, DW Chiu, RTP Poon, ... Liver Transplantation 19 (4), 411-419, 2013 | 152 | 2013 |
| Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma ACY Chan, RTP Poon, TT Cheung, KSH Chok, SC Chan, ST Fan, CM Lo World journal of surgery 36, 151-156, 2012 | 151 | 2012 |
| High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience KKC Ng, RTP Poon, SC Chan, KSH Chok, TT Cheung, H Tung, F Chu, ... Annals of surgery 253 (5), 981-987, 2011 | 150 | 2011 |
| Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B J Fung, SC Chan, C Cheung, MF Yuen, KSH Chok, W Sharr, ACY Chan, ... Official journal of the American College of Gastroenterology| ACG 108 (6 …, 2013 | 141 | 2013 |
| Host and viral determinants for efficient SARS-CoV-2 infection of the human lung H Chu, B Hu, X Huang, Y Chai, D Zhou, Y Wang, H Shuai, D Yang, Y Hou, ... Nature communications 12 (1), 134, 2021 | 129 | 2021 |
| Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma D Lee, IMJ Xu, DKC Chiu, J Leibold, APW Tse, MHR Bao, VWH Yuen, ... Hepatology 69 (4), 1768-1786, 2019 | 129 | 2019 |
| Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer DWH Ho, YM Tsui, KMF Sze, LK Chan, TT Cheung, E Lee, PC Sham, ... Cancer letters 459, 176-185, 2019 | 128 | 2019 |
| Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis G Berardi, Z Morise, C Sposito, K Igarashi, V Panetta, I Simonelli, S Kim, ... Journal of hepatology 72 (1), 75-84, 2020 | 127 | 2020 |
| Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: results up to 8 years J Fung, T Wong, K Chok, A Chan, TT Cheung, JWC Dai, S Sin, KW Ma, ... Hepatology 66 (4), 1036-1044, 2017 | 127 | 2017 |
